Your browser doesn't support javascript.
loading
Meta-analysis: the Effect of Lactobacillus Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Treatment
The Korean Journal of Helicobacter and Upper Gastrointestinal Research ; : 88-95, 2012.
Article in Korean | WPRIM | ID: wpr-221406
ABSTRACT
BACKGROUND/

AIMS:

Helicobacter pylori (H. pylori) is causally associated with gastritis and peptic ulcer diseases. Recent data have demonstrated that triple therapy with amoxicillin, clarithromycin, and a proton pump inhibitor has an eradication rate of only 74~76% and new therapeutic protocols may be necessary. The aim of this study was to investigate the effects of Lactobacillus as supplementation to anti-H. pylori regimens on H. pylori eradication rates and therapy-associated side effects. MATERIALS AND

METHODS:

The PubMed, Medline and Korean Medical Database were searched in January 2012, with no language restrictions, for randomized controlled trials; additional references were obtained from reviewed articles. We included trials comparing Lactobacillus supplementation to placebo or no treatment during anti-H. pylori regimens. Meta-analysis was performed with Review Manager.

RESULTS:

Eleven trials involving a total of 1,107 participants met the inclusion criteria. Compared with placebo or no intervention, Lactobacillus given along with anti-H. pylori regimens significantly increased the eradication rate [84.7% vs. 78.8%, odds ratio (OR) 1.75, 95% confidence interval (CI) 1.26~2.42] and reduced the risk of overall H. pylori therapy related adverse effects (35.4% vs. 48.6%, OR 0.56, 95% CI 0.38~0.81), particularly of diarrhea (7.5% vs. 20.6%, OR 0.31, 95% CI 0.18~0.54), bloating (19.2% vs. 29.9%, OR 0.53, 95% CI 0.32~0.88) and taste disturbance (17.6% vs. 34.8%, OR 0.37, 95% CI 0.21~0.64). There were no significant differences between groups in the risk of other adverse effects.

CONCLUSIONS:

Our review suggests that supplementation with Lactobacilli could be effective in increasing eradication rates of anti-H. pylori therapy. Furthermore, Lactobacilli showed a positive impact on some H. pylori therapy-related side effects, particularly diarrhea, bloating and taste disturbance.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Peptic Ulcer / Odds Ratio / Helicobacter pylori / Helicobacter / Proton Pumps / Clarithromycin / Diarrhea / Gastritis / Amoxicillin / Lactobacillus Type of study: Controlled clinical trial / Etiology study / Practice guideline / Systematic reviews Language: Korean Journal: The Korean Journal of Helicobacter and Upper Gastrointestinal Research Year: 2012 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Peptic Ulcer / Odds Ratio / Helicobacter pylori / Helicobacter / Proton Pumps / Clarithromycin / Diarrhea / Gastritis / Amoxicillin / Lactobacillus Type of study: Controlled clinical trial / Etiology study / Practice guideline / Systematic reviews Language: Korean Journal: The Korean Journal of Helicobacter and Upper Gastrointestinal Research Year: 2012 Type: Article